CTSO – cytosorbents corporation (US:NASDAQ)
Stock Stats
News
CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification
Cytosorbents Co. (NASDAQ: CTSO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Cytosorbents Co. (NASDAQ: CTSO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review
CytoSorbents to Report Third Quarter 2024 Operating and Financial Results
Form 4 Cytosorbents Corp For: Oct 04 Filed by: Deliargyris Efthymios
Form 4 Cytosorbents Corp For: Oct 04 Filed by: Capponi Vincent
Form 8-K Cytosorbents Corp For: Oct 01
Form 424B5 Cytosorbents Corp
Form 8-K Cytosorbents Corp For: Oct 01
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.